CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Insider Changes in Ownership
- 8-K Event Agreement ended
- 4 Grant or award CFO and Chief Corp. Deve. Off. acquired 311,100 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 311,100 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Regulation FD disclosure
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement · New debt or obligation
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Open-market sale Director sold 2,241,045 shares at an average $1.67 ($3,733,191)
- 4 Open-market sale President, CEO and Director sold 2,241,045 shares at an average $1.67 ($3,733,191)
- 144 Insider Sale of Securities
Page 4 of 26 · 506 filings